Plunkett Research Online: Proteon Therapeutics Inc

PROTEON THERAPEUTICS INC (PRTO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Proteon Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of novel pharmaceuticals to address the needs of patients with the renal and vascular disease......



Proteon Therapeutics Inc
Ticker: PRTO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 890-0102
Fax: 781 487-6729
Address: 200 West Street
Waltham, MA 02451 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
George EldridgeAssistant Secretary/CFO/Chief Accounting Officer/Senior VP/Treasurer
Paul HastingsChairman of the Board/Director
See More
Proteon Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of novel pharmaceuticals to address the needs of patients with the renal and vascular disease......See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: